<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="cfr.xsl"?>
<CFRGRANULE xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="CFRMergedXML.xsd">
  <FDSYS>
    <CFRTITLE>21</CFRTITLE>
    <CFRTITLETEXT>Food and Drugs</CFRTITLETEXT>
    <VOL>5</VOL>
    <DATE>2003-04-01</DATE>
    <ORIGINALDATE>2003-04-01</ORIGINALDATE>
    <COVERONLY>false</COVERONLY>
    <TITLE>Focused FDA regulatory research.</TITLE>
    <GRANULENUM>312.86</GRANULENUM>
    <HEADING>Section 312.86</HEADING>
    <ANCESTORS>
      <PARENT HEADING="Title 21" SEQ="4">Food and Drugs</PARENT>
      <PARENT HEADING="CHAPTER I" SEQ="3">FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED)</PARENT>
      <PARENT HEADING="SUBCHAPTER D" SEQ="2">DRUGS FOR HUMAN USE</PARENT>
      <PARENT HEADING="PART 312" SEQ="1">INVESTIGATIONAL NEW DRUG APPLICATION</PARENT>
      <PARENT HEADING="Subpart E" SEQ="0">Drugs Intended to Treat Life-threatening and Severely-debilitating Illnesses</PARENT>
    </ANCESTORS>
  </FDSYS>
  <SECTION>
    <SECTNO>§ 312.86</SECTNO>
    <SUBJECT>Focused FDA regulatory research.</SUBJECT>
    <P>At the discretion of the agency, FDA may undertake focused regulatory research on critical rate-limiting aspects of the preclinical, chemical/manufacturing, and clinical phases of drug development and evaluation. When initiated, FDA will undertake such research efforts as a means for meeting a public health need in facilitating the development of therapies to treat life-threatening or severely debilitating illnesses.</P>
  </SECTION>
</CFRGRANULE>
